Search Results
Niraparib Maintenance for Recurrent Ovarian Cancer
Niraparib Maintenance Therapy for Ovarian Cancer
Dr. Mirza on Efficacy of Niraparib/Bevacizumab Combo in Recurrent Ovarian Cancer
Niraparib as maintenance for platinum-sensitive ovarian cancer - results from ENGOT-OV16/NOVA trial
Dr. Westin on Niraparib Maintenance and Thrombocytopenia for Recurrent Ovarian Cancer
Niraparib Maintenance Therapy in Ovarian Cancer
Efficacy of Niraparib on PFS in Patients With Recurrent Ovarian Cancer
Results of Niraparib/Bevacizumab Combo in Platinum-Sensitive Recurrent Ovarian Cancer
Comment: Niraparib for ovarian cancer
New PARP Inhibitor Drug Approved to Treat Women with Recurrent Ovarian Cancer
PARP Inhibition in Recurrent Ovarian Cancer
PRIMA: Frontline Niraparib Maintenance Therapy in Ovarian Cancer
